-
Opinion: Why markets should matter to health advocates
Today, one of global health’s biggest challenges — and opportunities — lies in strengthening the markets that make health products, services, and technologies available to those who need them most.
- Categories
- Health Care
- Tags
- public health
-
Funding a set of essential medicines for low- and middle-income countries
As the world moves toward universal health coverage, the question arises: How can governments ensure equitable access to essential medicines in low- and middle-income countries?
- Categories
- Health Care
- Tags
- public health
-
Re-evaluating the ‘cost’ of life: Cancer-preventing HPV vaccines are substantially over-priced, says study
A recent study by leading American health researchers reveals that the manufacturing costs for the two most prevalent Human Papilloma Virus (HPV) vaccines could be priced much lower than even their quoted ‘no profit’ price, thus potentially having a substantial impact on the global morbidity and mortality rates associated with cervical cancer.
- Categories
- Health Care
- Tags
- vaccines
-
Merck Opens China Pharmaceutical Plant
The world's leading biomedicine company Merck has opened a plant in Nantong, China's eastern Jiangsu Province, to produce pharmaceuticals on the country's Essential Drug List.
- Categories
- Health Care
- Region
- South Asia
-
As health system collapses, Zimbabwe turns to street herbs
Zimbabwe’s public health system is collapsing along with the economy, with some major hospitals suspending all non-emergency surgeries because painkillers are scarce.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
UNFPA takes sexual health accelerator to Uganda
The United Nations Population Fund (UNFPA) has taken its sexual health-related iAccelerator to Uganda in collaboration with Kampala-based hub Outbox following a successful launch in Nairobi.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
These Researchers Think They Have a Solution to the Global Crisis in Drug Prices
Jerome Zeldis remembers exactly how he felt when he heard about the $84,000 price tag on a powerful new hepatitis C treatment three years ago. “I was somewhere between annoyed and outraged,” recalled Zeldis, the former chief medical officer of the biotech juggernaut Celgene.
- Categories
- Health Care
- Tags
- research
-
Namibia Welcomes its First Batch of Locally Trained Doctors
Patients in Namibia can now be treated by locally trained doctors who the government hopes will help transform the country’s health sector, according to BBC. Before the country’s first medical school was opened in 2010, medical students in Namibia had to seek training overseas. Some went to neighboring South Africa, while others traveled to as far as Russia and China.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health, research
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.